Kiyosumi Ochi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chimera | 1 | 2021 | 454 | 0.680 |
Why?
|
Splenic Neoplasms | 1 | 2017 | 97 | 0.530 |
Why?
|
Antilymphocyte Serum | 1 | 2018 | 492 | 0.520 |
Why?
|
Hematopoietic Stem Cells | 2 | 2021 | 3408 | 0.500 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 180 | 0.490 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 147 | 0.490 |
Why?
|
Hemoglobin Subunits | 1 | 2014 | 1 | 0.480 |
Why?
|
beta-Globins | 1 | 2014 | 112 | 0.440 |
Why?
|
Erythropoiesis | 2 | 2014 | 693 | 0.430 |
Why?
|
Bone Marrow Transplantation | 1 | 2021 | 2709 | 0.430 |
Why?
|
Bone Marrow | 1 | 2021 | 2935 | 0.360 |
Why?
|
Pluripotent Stem Cells | 2 | 2014 | 810 | 0.300 |
Why?
|
Flow Cytometry | 2 | 2014 | 5905 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3626 | 0.200 |
Why?
|
Transplantation Chimera | 1 | 2021 | 594 | 0.150 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2018 | 37 | 0.150 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2018 | 168 | 0.140 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1209 | 0.130 |
Why?
|
Genetic Engineering | 1 | 2021 | 936 | 0.120 |
Why?
|
bcl-X Protein | 2 | 2014 | 412 | 0.120 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2017 | 263 | 0.120 |
Why?
|
Splenectomy | 1 | 2017 | 392 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2021 | 2414 | 0.110 |
Why?
|
gamma-Globins | 1 | 2014 | 105 | 0.110 |
Why?
|
Erythroblasts | 1 | 2013 | 142 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 524 | 0.110 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5195 | 0.110 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.100 |
Why?
|
Molecular Probes | 1 | 2014 | 309 | 0.100 |
Why?
|
Genes, myc | 1 | 2013 | 391 | 0.100 |
Why?
|
Antigens, CD34 | 1 | 2014 | 656 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2021 | 2059 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5716 | 0.090 |
Why?
|
Transplantation Conditioning | 1 | 2018 | 1601 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2014 | 998 | 0.090 |
Why?
|
Coculture Techniques | 1 | 2014 | 1342 | 0.090 |
Why?
|
Embryonic Stem Cells | 2 | 2014 | 1251 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2475 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4835 | 0.080 |
Why?
|
Megakaryocytes | 1 | 2014 | 571 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1769 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2014 | 11684 | 0.070 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.070 |
Why?
|
Mutation | 2 | 2024 | 30266 | 0.070 |
Why?
|
Transfection | 1 | 2014 | 5763 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1181 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12873 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 2986 | 0.050 |
Why?
|
Blood Platelets | 1 | 2014 | 2479 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3613 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22381 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1891 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4940 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 7885 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 223740 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5803 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 1839 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2631 | 0.040 |
Why?
|
Blast Crisis | 1 | 2017 | 102 | 0.040 |
Why?
|
Bone Marrow Neoplasms | 1 | 2017 | 101 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11886 | 0.030 |
Why?
|
Male | 5 | 2024 | 365249 | 0.030 |
Why?
|
Mice | 2 | 2021 | 82074 | 0.030 |
Why?
|
Pyridazines | 1 | 2017 | 203 | 0.030 |
Why?
|
Drug Substitution | 1 | 2017 | 291 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2024 | 2059 | 0.030 |
Why?
|
Recurrence | 2 | 2017 | 8512 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2960 | 0.030 |
Why?
|
Humans | 9 | 2024 | 768887 | 0.030 |
Why?
|
Female | 5 | 2024 | 397464 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2013 | 205 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1836 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2013 | 148 | 0.030 |
Why?
|
Animals | 3 | 2021 | 169408 | 0.030 |
Why?
|
GATA1 Transcription Factor | 1 | 2013 | 306 | 0.030 |
Why?
|
Time Factors | 1 | 2014 | 40266 | 0.030 |
Why?
|
Aged | 3 | 2024 | 171790 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 626 | 0.020 |
Why?
|
Imidazoles | 1 | 2017 | 1169 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2126 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2013 | 902 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223818 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 65485 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4862 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 930 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1531 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1667 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3050 | 0.020 |
Why?
|
Prognosis | 1 | 2024 | 30044 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9384 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4273 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59738 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19023 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11934 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18366 | 0.010 |
Why?
|